Musaffa Logo
Amneal Pharmaceuticals Inc 2DT.SG

Last Updated: Jul 13, 12:00 AM·XSTU

2DT.SG Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Amneal Pharmaceuticals Inc is classified as not halal.

NOT HALAL

Report Source: 2026 1st Quarter Report

Amneal Pharmaceuticals Inc

Amneal Pharmaceuticals Inc. Stock Analysis 2DT.SG

Germany Health Care Mid Cap Report:
Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. The company is headquartered in Bridgewater, New Jersey and currently employs 8,500 full-time employees. The company went IPO on 2009-11-18. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
Read More

Amneal Pharmaceuticals Inc (2DT.SG) Chart

Key Statistics of Amneal Pharmaceuticals Inc (2DT.SG)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€14.60€15.00

Today's Open

€14.60

Volume

200.00

P/E Ratio (TTM)

79.73

Financial Metrics & Statements of Amneal Pharmaceuticals Inc (2DT.SG)

Super Investors Invested in Amneal Pharmaceuticals Inc (2DT.SG)

FAQ's for Amneal Pharmaceuticals Inc (2DT.SG)

  • As of July 2026, Amneal Pharmaceuticals Inc 2DT.SG is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Amneal Pharmaceuticals Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Amneal Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Amneal Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Amneal Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Amneal Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.